연구성과로 돌아가기
JCR 2024 저널 목록 (773 / 2104)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHIRALITY | WILEY | 0899-0042 | 1520-636X | SCIE | PHARMACOLOGY & PHARMACY | 3,374 | 3.0 | Q2 | 39.1 | 60.9 | 138/352 | 2.3 | Q3 | 2.9 | 0.4 | 0.67 | 173/353 | Q2 | 51.13 | 0.002 | 0.385 | 0.422 | Q3 | 82 | 87.8% | 8.9 | 9.3 | 72 | 22.2% | 2025-08-05 16:04:34 | 바로가기 |
| CNS & Neurological Disorders-Drug Targets | BENTHAM SCIENCE PUBL | 1871-5273 | 1996-3181 | SCIE | PHARMACOLOGY & PHARMACY | 3,821 | 3.0 | Q2 | 39.1 | 60.9 | 138/352 | 2.8 | Q2 | 2.9 | 1.2 | 0.63 | 189/353 | Q3 | 46.60 | 0.002 | 0.381 | 0.522 | Q3 | 129 | 26.4% | 8.1 | 9.5 | 34 | 0.9% | 2025-08-05 16:04:34 | 바로가기 |
| Colloid and Interface Science Communications | ELSEVIER | 2215-0382 | 2215-0382 | SCIE | NANOSCIENCE & NANOTECHNOLOGY | 3,087 | 4.7 | Q2 | 39.1 | 60.9 | 58/147 | 4.7 | Q2 | 4.5 | 1.5 | 0.76 | 59/147 | Q2 | 60.20 | 0.003 | 0.634 | 0.617 | Q3 | 48 | 100.0% | 3.5 | 4.8 | 48 | 97.1% | 2025-08-05 16:04:17 | 바로가기 |
| CPT-Pharmacometrics & Systems Pharmacology | WILEY | 2163-8306 | 2163-8306 | SCIE | PHARMACOLOGY & PHARMACY | 4,051 | 3.0 | Q2 | 39.1 | 60.9 | 138/352 | 3.8 | Q2 | 2.7 | 0.7 | 0.93 | 92/353 | Q2 | 74.08 | 0.005 | 1.187 | 1.160 | Q1 | 177 | 95.5% | 5.3 | 8.0 | 169 | 89.4% | 2025-08-05 16:04:34 | 바로가기 |
| Current Drug Delivery | BENTHAM SCIENCE PUBL LTD | 1567-2018 | 1875-5704 | SCIE | PHARMACOLOGY & PHARMACY | 3,273 | 3.0 | Q2 | 39.1 | 60.9 | 138/352 | 2.9 | Q2 | 2.9 | 1.5 | 0.73 | 144/353 | Q2 | 59.35 | 0.002 | 0.348 | 0.390 | Q3 | 140 | 46.4% | 5.8 | 6.8 | 65 | 1.1% | 2025-08-05 16:04:34 | 바로가기 |
| Epilepsia Open | WILEY | N/A | 2470-9239 | SCIE | CLINICAL NEUROLOGY | 2,158 | 2.9 | Q2 | 39.1 | 60.9 | 112/285 | 3.3 | Q2 | 2.7 | 0.5 | 0.81 | 108/285 | Q2 | 62.28 | 0.004 | 0.867 | 1.027 | Q2 | 218 | 85.8% | 3.6 | 7.7 | 187 | 90.6% | 2025-08-05 16:02:42 | 바로가기 |
| Expert Review of Clinical Pharmacology | TAYLOR & FRANCIS LTD | 1751-2433 | 1751-2441 | SCIE | PHARMACOLOGY & PHARMACY | 3,577 | 3.0 | Q2 | 39.1 | 60.9 | 138/352 | 3.5 | Q2 | 2.9 | 0.8 | 0.67 | 173/353 | Q2 | 51.13 | 0.004 | 0.955 | 0.964 | Q1 | 84 | 38.1% | 5.2 | 6.1 | 32 | 13.5% | 2025-08-05 16:04:34 | 바로가기 |
| Future Journal of Pharmaceutical Sciences | SPRINGER | 2314-7245 | 2314-7253 | ESCI | PHARMACOLOGY & PHARMACY | 2,553 | 3.0 | Q2 | 39.1 | 60.9 | 138/352 | 3.8 | Q2 | 2.9 | 0.7 | 0.70 | 158/353 | Q2 | 55.38 | 0.002 | 0.483 | 0.487 | Q3 | 178 | 75.8% | 3.6 | 7.3 | 135 | 99.7% | 2025-08-05 16:04:34 | 바로가기 |
| IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY | TAYLOR & FRANCIS LTD | 0892-3973 | 1532-2513 | SCIE | PHARMACOLOGY & PHARMACY | 2,947 | 3.0 | Q2 | 39.1 | 60.9 | 138/352 | 3.1 | Q2 | 3.0 | 0.4 | 0.82 | 115/353 | Q2 | 67.56 | 0.002 | 0.431 | 0.557 | Q3 | 82 | 86.6% | 6.4 | 6.2 | 71 | 4.0% | 2025-08-05 16:04:34 | 바로가기 |
| IRONMAKING & STEELMAKING | SAGE PUBLICATIONS INC | 0301-9233 | 1743-2812 | SCIE | METALLURGY & METALLURGICAL ENGINEERING | 4,344 | 2.2 | Q2 | 39.1 | 60.9 | 38/96 | 2.6 | Q2 | 1.7 | 0.4 | 0.43 | 39/96 | Q2 | 59.90 | 0.002 | 0.410 | 0.348 | Q2 | 272 | 97.8% | 7.4 | 7.0 | 266 | 4.6% | 2025-08-05 16:04:12 | 바로가기 |
| Italian Journal of Dermatology and Venereology | EDIZIONI MINERVA MEDICA | 2784-8671 | 2784-8450 | SCIE | DERMATOLOGY | 482 | 2.6 | Q2 | 39.1 | 60.9 | 38/96 | 2.4 | Q2 | 2.5 | 0.6 | 0.65 | 48/96 | Q2 | 50.52 | 0.001 | 0.196 | 0.607 | Q2 | 62 | 56.4% | 2.5 | 6.6 | 35 | 5.4% | 2025-08-05 16:02:51 | 바로가기 |
| Journal of Clinical Sleep Medicine | AMER ACAD SLEEP MEDICINE | 1550-9389 | 1550-9397 | SCIE | CLINICAL NEUROLOGY | 11,988 | 2.9 | Q2 | 39.1 | 60.9 | 112/285 | 3.8 | Q2 | 2.7 | 0.8 | 1.08 | 63/285 | Q1 | 78.07 | 0.010 | 2.288 | 1.140 | Q2 | 213 | 96.2% | 7.3 | 8.6 | 205 | 3.8% | 2025-08-05 16:02:42 | 바로가기 |
| Journal of Diversity in Higher Education | EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC | 1938-8926 | 1938-8934 | SSCI | PSYCHOLOGY, SOCIAL | 2,285 | 2.4 | Q2 | 39.1 | 60.9 | 31/78 | 3.7 | Q2 | 2.1 | 0.3 | 1.15 | 20/78 | Q2 | 75.00 | 0.004 | 0.791 | 1.187 | Q2 | 88 | 98.9% | 4.3 | 7.8 | 87 | 11.8% | 2025-08-05 16:04:57 | 바로가기 |
| JOURNAL OF EQUINE VETERINARY SCIENCE | ELSEVIER SCIENCE INC | 0737-0806 | 1542-7412 | SCIE | VETERINARY SCIENCES | 3,786 | 1.6 | Q2 | 39.1 | 60.9 | 67/170 | 1.5 | Q2 | 1.5 | 0.3 | 0.71 | 68/170 | Q2 | 60.29 | 0.002 | 0.553 | 0.287 | Q3 | 152 | 96.0% | 6.5 | 11.6 | 146 | 20.5% | 2025-08-05 16:05:31 | 바로가기 |
| JOURNAL OF FOOD AND DRUG ANALYSIS | DIGITAL COMMONS BEPRESS | 1021-9498 | 1021-9498 | SCIE | PHARMACOLOGY & PHARMACY | 5,429 | 3.0 | Q2 | 39.1 | 60.9 | 138/352 | 5.1 | Q1 | 2.9 | 0.4 | 0.66 | 177/353 | Q3 | 50.00 | 0.002 | 0.406 | 0.808 | Q2 | 40 | 90.0% | 7.6 | 5.5 | 36 | 81.3% | 2025-08-05 16:04:34 | 바로가기 |
페이지 이동: